Acrivon Therapeutics shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $41k | 23k | 1.81 |
| 2025-06-30 | $27k | 23k | 1.19 |
| 2025-03-31 | $158k | 78k | 2.03 |
| 2024-12-31 | $449k | 75k | 6.02 |
| 2024-09-30 | $539k | 77k | 7.00 |
| 2024-06-30 | $337k | 58k | 5.80 |
| 2024-03-31 | $416k | 58k | 7.15 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management